Risk factors for loss of skeletal muscle mass in patients with chronic kidney disease on a low-protein diet
Nutrition · 2026
DOI: 10.1016/j.nut.2026.113344 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Nutrition, 2026. Verfasst von Satoko Notomi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition Science, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata City, Ni…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Diet, Protein-Restricted, Muscle, Skeletal, Sarcopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVES: A low-protein diet (LPD) is recommended for patients with chronic kidney disease (CKD) to prevent a further decline in renal function. However, its impact on muscle mass in these patients remains unclear. This study investigated the risk factors for loss of muscle mass in patients with CKD on an LPD. METHODS: Eighty-four patients with predialysis CKD (59 men, mean age 61.9 ± 11.5 y) who participated in a multicenter randomized controlled trial initiated in 2014 were retrospectively reviewed. We collected data on baseline blood and urine tests, body composition, and dietary records at the start and end of the observation period. We evaluated muscle mass using the skeletal muscle index (SMI) and analyzed risk factors for a decrease in SMI during the 24-wk observation period, using logistic regression analysis. Variables with an association (P < 0.1) in univariate analysis, as well as age, sex, use of low-protein rice, and changes in protein intake, were subjected to multivariate analysis. RESULTS: SMI decreased in 50 patients (59.5%) during the observation period. Multivariate analysis identified significant associations of the SMI with serum albumin at baseline (odds ratio 0.11, 95% confidence interval 0.02-0.52, P = 0.004) and changes in energy intake while on the LPD (odds ratio 3.39, 95% confidence interval 1.00-11.43, P = 0.049). CONCLUSIONS: Risk factors for reduced SMI in patients with CKD on an LPD were malnutrition when initiating the LPD and reduced energy intake during its implementation. Clinicians should optimize nutritional status before initiation of an LPD and ensure adequate energy intake throughout treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Nutrition Science, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata City, Niigata, Japan; Division of Clinical Nephrology and Rheumatology, Kidney…
- Department of Clinical Nutrition Science, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata City, Niigata, Japan; Aizubange Center for Nephrology and Clinical Nutrition,…
- Department of Health and Nutrition, University of Niigata Prefecture Faculty of Human Life Studies, Niigata City, Niigata, Japan.
- Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata City, Niigata, Japan.
Zitieren
APA
Notomi, S., Kabasawa, H., Murayama, T., Tanaka, M., Yamamoto, S., & Hosojima, M. (2026). Risk factors for loss of skeletal muscle mass in patients with chronic kidney disease on a low-protein diet. Nutrition. https://doi.org/10.1016/j.nut.2026.113344
Vancouver
Notomi S, Kabasawa H, Murayama T, Tanaka M, Yamamoto S, Hosojima M. Risk factors for loss of skeletal muscle mass in patients with chronic kidney disease on a low-protein diet. Nutrition. 2026. doi:10.1016/j.nut.2026.113344
BibTeX
@article{Notomi2026,
author = {Notomi, Satoko and Kabasawa, Hideyuki and Murayama, Toshiko and Tanaka, Mai and Yamamoto, Suguru and Hosojima, Michihiro},
title = {Risk factors for loss of skeletal muscle mass in patients with chronic kidney disease on a low-protein diet},
journal = {Nutrition},
year = {2026},
doi = {10.1016/j.nut.2026.113344}
}
EUVIMED